Unveiling the main factors triggering the coagulation at the SiC-blood interface
Zümray Vuslat Parlak1, Norina Labude-Weber2, Kerstin Neuhaus3
1Department of Ceramics, Institute of Mineral Engineering, RWTH Aachen University, Aachen, Germany.
Journal of Biomedical Materials Research. Part A
|March 16, 2023
Summary
Surface properties of silicon carbide (SiC) single crystals significantly impact blood compatibility. Understanding SiC surface termination is key to controlling platelet activation and designing advanced hemocompatible biomaterials.
Area of Science:
- Biomaterials Science
- Surface Chemistry
- Hemocompatibility Studies
Background:
- Hemocompatibility is crucial for blood-contacting medical devices, requiring rigorous in vitro testing per ISO 10993-4.
- Surface structure and chemistry critically influence blood cell behavior and biomaterial performance.
- Silicon carbide (SiC) is a promising biomaterial, but its hemocompatibility requires detailed surface characterization.
Purpose of the Study:
- To investigate the influence of SiC single crystal surface terminations and polymorphs on initial blood contact coagulation.
- To correlate surface properties (phase, roughness, potential, wettability) with cytotoxicity and hemocompatibility.
- To elucidate the role of SiC surface termination in platelet activation and cellular anisotropy.
Main Methods:
- Analysis of SiC single crystal phase, roughness, surface potential, and wettability.
- In vitro hemocompatibility assessment using live/dead staining, live cell imaging, ELISA, and Micro BCA protein assay.
- Evaluation of cytotoxicity and platelet activation on different SiC surfaces.
Main Results:
- SiC surface potential and wettability are dependent on crystallographic polymorph and surface termination.
- SiC surface termination critically influences platelet activation, a novel finding.
- In vitro analyses confirmed the link between surface properties and cellular responses, highlighting cellular anisotropy.
Conclusions:
- SiC surface termination is a primary determinant of hemocompatibility.
- Tailoring SiC surface properties can optimize hemocompatibility for biomedical applications.
- This research provides a foundation for developing advanced SiC-based biomaterials with enhanced blood compatibility.
Related Concept Videos
01:20Extrinsic and Intrinsic Pathways of Hemostasis
8.6K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
8.6K
01:09Coagulation
7.2K
The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
7.2K
01:05Introduction to Hemostasis
8.5K
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
8.5K
01:22Formation of the Platelet Plug
6.8K
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
6.8K
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
795
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
795
01:16Clot Retraction and Fibrinolysis
6.6K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
6.6K